Carter Bankshares (CARE) Regulation FD Filing Discloses CEO Medical Update

Rhea-AI Filing Summary

Carter Bankshares disclosed that Chief Executive Officer Litz H. Van Dyke shared a letter with employees informing them of a recent medical update. The company furnished that letter as Exhibit 99.1 under a Regulation FD disclosure. The filing contains no financial metrics, operating details, transaction information, or statements about changes to leadership, succession plans, or business operations. The report is signed on the company’s behalf by Chief Financial Officer Wendy S. Bell. The 8-K therefore communicates the CEO’s employee-facing medical update without providing any information about material impacts to the company’s financial position or operations.

Insights

Corporate Governance Expert

TL;DR: Disclosure informs employees of the CEO's medical update but does not provide governance actions or impact details.

The 8-K is a Regulation FD disclosure that attaches the CEO's letter to employees as Exhibit 99.1. It contains no statements about leadership changes, interim management, or board actions. From a governance perspective, the filing provides transparency about internal communication but does not supply data required to assess changes in corporate control or governance. The disclosure is limited in scope and does not by itself indicate material governance implications.

Risk Analyst

TL;DR: The filing reports a CEO medical update to staff but includes no operational, financial, or risk-impacting details.

The 8-K confirms the CEO communicated a medical update to employees and that the letter is attached as Exhibit 99.1. The document does not disclose any operational disruptions, financial impacts, contingency plans, or risk mitigation measures. Given the absence of quantitative or operational information, this disclosure does not allow assessment of enterprise-level risk changes based solely on the filing.

0001829576false00018295762025-08-112025-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20429

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 11, 2025

CARTER BANKSHARES, INC.

(Exact name of registrant as specified in its charter)

Virginia			001-39731			85-3365661
(State or other jurisdiction of incorporation)			(Commission file number)			(IRS Employer Identification No.)

1300 Kings Mountain Road, Martinsville, Virginia 24112

(Address of Principal Executive Offices) (Zip Code)

(276) 656-1776

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $1.00 par value			CARE			NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 7.01. - Regulation FD Disclosure.

On August 11, 2025, Litz H. Van Dyke, Chief Executive Officer of Carter Bankshares, Inc., shared a letter with employees informing them of a recent medical update. A copy of this letter is attached as Exhibit 99.1.

ITEM 9.01. - Exhibits.

(d) Exhibits.

Exhibit No.    Description

99.1        Letter to employees from Litz H. Van Dyke, Chief Executive Officer of Carter Bankshares, Inc.

104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CARTER BANKSHARES, INC.

(Registrant)

Date: August 11, 2025			By:			/s/ Wendy S. Bell
			Name:			Wendy S. Bell
			Title:			Chief Financial Officer

FAQ

What did Carter Bankshares (CARE) disclose in this Form 8-K?

The company disclosed that CEO Litz H. Van Dyke shared a letter with employees about a recent medical update; the letter is attached as Exhibit 99.1.

Does the 8-K describe any financial or operational impact from the CEO's medical update?

No. The filing contains no financial metrics, operational details, transactions, or statements about impacts to the business.

Who signed the 8-K for Carter Bankshares (CARE)?

The report was signed on the company's behalf by Wendy S. Bell, Chief Financial Officer.

Under what provision was the disclosure made?

The disclosure was furnished under Regulation FD and the CEO's letter is provided as Exhibit 99.1.

Is there any information about leadership changes or succession in the filing?

No. The filing does not mention leadership changes, succession plans, interim arrangements, or board actions.